Neuromuscular Diseases

  • Fabrizio Racca
  • Brunella Gily


Patients affected by neuromuscular disorders are at high risk of intraoperative and postoperative complications. General anesthesia in these patients may exacerbate respiratory and cardiovascular failure due to a marked sensitivity to several anesthetic drugs. Moreover, succinylcholine and halogenated agents can trigger life-threatening reactions. Thus, in these children, a proactive and multidisciplinary approach should be instituted before, during, and after any surgical procedure requiring general anesthesia or sedation. This chapter will review the pathophysiology of life-threatening complications of anesthesia in NMDs and the assessment and management of these patients before, during, and after anesthesia.


Anesthesia Neuromuscular diseases Noninvasive ventilation Mechanical insufflation-exsufflation Malignant hyperthermia 


  1. 1.
    Racca F, Mongini T, Wolfler A, et al. Recommendations for Anesthesia and Perioperative management of patients with neuromuscular disorders. Minerva Anestesiol. 2013;79:419–33.PubMedPubMedCentralGoogle Scholar
  2. 2.
    Hull J, Aniapravan R, Chan E, Chatwin M, Forton J, Gallagher J, Gibson N, Gordon J, Hughes I, McCulloch R, Russell RR, Simonds A. British Thoracic Society guideline for respiratory management of children with neuromuscular weakness. Thorax. 2012;67:i1ei40.CrossRefGoogle Scholar
  3. 3.
    Bushby K, Finkel R, Birnkrant DJ, et al. Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. Lancet Neurol. 2010;9(2):177–89.CrossRefGoogle Scholar
  4. 4.
    Marik PE, Varon J. Requirement of perioperative stress doses of corticosteroids: a systematic review of the literature. Arch Surg. 2008;143(12):1222–6.CrossRefGoogle Scholar
  5. 5.
    Yong SL, Marik P, Esposito M, Coulthard P. Supplemental perioperative steroids for surgical patients with adrenal insufficiency. Cochrane Database Syst Rev. 2009;(4):CD005367.Google Scholar
  6. 6.
    Petrini F, Accorsi A, Adrario E, et al. Recommendations for airway control and difficult airway management. Minerva Anestesiol. 2005;71(11):617–57.Google Scholar
  7. 7.
    Frova G, Guarino A, Petrini F, et al. Recommendations for airway control and difficult airway management in paediatric patients. Minerva Anestesiol. 2006;72(9):723–48.PubMedGoogle Scholar
  8. 8.
    Wappler F. Malignant hyperthermia. Eur J Anaesthesiol. 2001;18:632.CrossRefGoogle Scholar
  9. 9.
    Brady JE, Sun LS, Rosenberg H, Li G. Prevalence of malignant hyperthermia due to anesthesia in New York State, 2001-2005. Anesth Analg. 2009;109:1162.CrossRefGoogle Scholar
  10. 10.
    Glahn KPE, et al. Recognizing and managing a malignant hyperthermia crisis: guidelines from the European Malignant Hyperthermia Group. Br J Anaesth. 2010;105(4):417–20.CrossRefGoogle Scholar
  11. 11.
    Veyckemans F. Can inhalation agents be used in the presence of a child with myopathy? Curr Opin Anaesthesiol. 2010;23(3):348–55.CrossRefGoogle Scholar
  12. 12.
    de Boer HD, van Esmond J, Booij LH, Driessen JJ. Reversal of rocuronium-induced profound neuromuscular block by sugammadex in Duchenne muscular dystrophy. Paediatr Anaesth. 2009;19(12):1226–8.CrossRefGoogle Scholar
  13. 13.
    Unterbuchner C, Fink H, Blobner M. The use of sugammadex in a patient with myasthenia gravis. Anaesthesia. 2010;65(3):302–5.CrossRefGoogle Scholar
  14. 14.
    Bach JR, Goncalves MR, Hamdani I, Winck JC. Extubation of patients with neuromuscular weakness: a new management paradigm. Chest. 2010;137(5):1033–9.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Fabrizio Racca
    • 1
  • Brunella Gily
    • 1
  1. 1.Department of Anesthesiology and Intensive CareSS Antonio Biagio e Cesare Arrigo HospitalAlessandriaItaly

Personalised recommendations